Detailed TOC of Global Newcastle Disease Vaccine Market Research Report 2025
1 Newcastle Disease Vaccine Market Overview
1.1 Product Definition
1.2 Newcastle Disease Vaccine by Type
1.2.1 Global Newcastle Disease Vaccine Market Value Comparison by Type (2025 VS 2031)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Newcastle Disease Vaccine by Application
1.3.1 Global Newcastle Disease Vaccine Market Value by Application (2025 VS 2031)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts
1.4.1 Global Newcastle Disease Vaccine Revenue 2020-2031
1.4.2 Global Newcastle Disease Vaccine Sales 2020-2031
1.4.3 Global Newcastle Disease Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Newcastle Disease Vaccine Market Competition by Manufacturers
2.1 Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Newcastle Disease Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Newcastle Disease Vaccine, Industry Ranking, 2025 VS 2025 VS 2025
2.5 Global Key Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Newcastle Disease Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Newcastle Disease Vaccine, Date of Enter into This Industry
2.8 Global Newcastle Disease Vaccine Market Competitive Situation and Trends
2.8.1 Global Newcastle Disease Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Newcastle Disease Vaccine Players Market Share by Revenue
2.8.3 Global Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Newcastle Disease Vaccine Market Scenario by Region
3.1 Global Newcastle Disease Vaccine Market Size by Region: 2020 Versus 2025 Versus 2031
3.2 Global Newcastle Disease Vaccine Sales by Region: 2020-2031
3.2.1 Global Newcastle Disease Vaccine Sales by Region: 2020-2025
3.2.2 Global Newcastle Disease Vaccine Sales by Region: 2026-2031
3.3 Global Newcastle Disease Vaccine Revenue by Region: 2020-2031
3.3.1 Global Newcastle Disease Vaccine Revenue by Region: 2020-2025
3.3.2 Global Newcastle Disease Vaccine Revenue by Region: 2026-2031
3.4 North America Newcastle Disease Vaccine Market Facts & Figures by Country
3.4.1 North America Newcastle Disease Vaccine Market Size by Country: 2020 VS 2025 VS 2031
3.4.2 North America Newcastle Disease Vaccine Sales by Country (2020-2031)
3.4.3 North America Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Newcastle Disease Vaccine Market Facts & Figures by Country
3.5.1 Europe Newcastle Disease Vaccine Market Size by Country: 2020 VS 2025 VS 2031
3.5.2 Europe Newcastle Disease Vaccine Sales by Country (2020-2031)
3.5.3 Europe Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Newcastle Disease Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Newcastle Disease Vaccine Market Size by Region: 2020 VS 2025 VS 2031
3.6.2 Asia Pacific Newcastle Disease Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Newcastle Disease Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Newcastle Disease Vaccine Market Facts & Figures by Country
3.7.1 Latin America Newcastle Disease Vaccine Market Size by Country: 2020 VS 2025 VS 2031
3.7.2 Latin America Newcastle Disease Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Newcastle Disease Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Newcastle Disease Vaccine Market Size by Country: 2020 VS 2025 VS 2031
3.8.2 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Newcastle Disease Vaccine Sales by Type (2020-2031)
4.1.1 Global Newcastle Disease Vaccine Sales by Type (2020-2025)
4.1.2 Global Newcastle Disease Vaccine Sales by Type (2026-2031)
4.1.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Newcastle Disease Vaccine Revenue by Type (2020-2031)
4.2.1 Global Newcastle Disease Vaccine Revenue by Type (2020-2025)
4.2.2 Global Newcastle Disease Vaccine Revenue by Type (2026-2031)
4.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Newcastle Disease Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Newcastle Disease Vaccine Sales by Application (2020-2031)
5.1.1 Global Newcastle Disease Vaccine Sales by Application (2020-2025)
5.1.2 Global Newcastle Disease Vaccine Sales by Application (2026-2031)
5.1.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Newcastle Disease Vaccine Revenue by Application (2020-2031)
5.2.1 Global Newcastle Disease Vaccine Revenue by Application (2020-2025)
5.2.2 Global Newcastle Disease Vaccine Revenue by Application (2026-2031)
5.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Newcastle Disease Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merial
6.1.1 Merial Company Information
6.1.2 Merial Description and Business Overview
6.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merial Newcastle Disease Vaccine Product Portfolio
6.1.5 Merial Recent Developments/Updates
6.2 CEVA
6.2.1 CEVA Company Information
6.2.2 CEVA Description and Business Overview
6.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
6.2.5 CEVA Recent Developments/Updates
6.3 QYH Biotech
6.3.1 QYH Biotech Company Information
6.3.2 QYH Biotech Description and Business Overview
6.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
6.3.5 QYH Biotech Recent Developments/Updates
6.4 Ringpu Biology
6.4.1 Ringpu Biology Company Information
6.4.2 Ringpu Biology Description and Business Overview
6.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
6.4.5 Ringpu Biology Recent Developments/Updates
6.5 Yebio
6.5.1 Yebio Company Information
6.5.2 Yebio Description and Business Overview
6.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
6.5.5 Yebio Recent Developments/Updates
6.6 Harbin Veterinary Research Institute
6.6.1 Harbin Veterinary Research Institute Company Information
6.6.2 Harbin Veterinary Research Institute Description and Business Overview
6.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
6.6.5 Harbin Veterinary Research Institute Recent Developments/Updates
6.7 Merck Animal Health
6.7.1 Merck Animal Health Company Information
6.7.2 Merck Animal Health Description and Business Overview
6.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 DHN
6.8.1 DHN Company Information
6.8.2 DHN Description and Business Overview
6.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DHN Newcastle Disease Vaccine Product Portfolio
6.8.5 DHN Recent Developments/Updates
6.9 Zoetis
6.9.1 Zoetis Company Information
6.9.2 Zoetis Description and Business Overview
6.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
6.9.5 Zoetis Recent Developments/Updates
6.10 ChengDu Tecbond
6.10.1 ChengDu Tecbond Company Information
6.10.2 ChengDu Tecbond Description and Business Overview
6.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
6.10.5 ChengDu Tecbond Recent Developments/Updates
6.11 Elanco (Lohmann)
6.11.1 Elanco (Lohmann) Company Information
6.11.2 Elanco (Lohmann) Description and Business Overview
6.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
6.11.5 Elanco (Lohmann) Recent Developments/Updates
6.12 FATRO
6.12.1 FATRO Company Information
6.12.2 FATRO Description and Business Overview
6.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
6.12.5 FATRO Recent Developments/Updates
6.13 CAVAC
6.13.1 CAVAC Company Information
6.13.2 CAVAC Description and Business Overview
6.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
6.13.5 CAVAC Recent Developments/Updates
6.14 Vaksindo
6.14.1 Vaksindo Company Information
6.14.2 Vaksindo Description and Business Overview
6.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
6.14.5 Vaksindo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Newcastle Disease Vaccine Industry Chain Analysis
7.2 Newcastle Disease Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Newcastle Disease Vaccine Production Mode & Process Analysis
7.4 Newcastle Disease Vaccine Sales and Marketing
7.4.1 Newcastle Disease Vaccine Sales Channels
7.4.2 Newcastle Disease Vaccine Distributors
7.5 Newcastle Disease Vaccine Customer Analysis
8 Newcastle Disease Vaccine Market Dynamics
8.1 Newcastle Disease Vaccine Industry Trends
8.2 Newcastle Disease Vaccine Market Drivers
8.3 Newcastle Disease Vaccine Market Challenges
8.4 Newcastle Disease Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Download FREE Sample Report
